ATE485279T1 - Verbessertes verfahren zur herstellung der salze von 4-(benzimidazolylmethylamin)-benzamiden - Google Patents

Verbessertes verfahren zur herstellung der salze von 4-(benzimidazolylmethylamin)-benzamiden

Info

Publication number
ATE485279T1
ATE485279T1 AT06830756T AT06830756T ATE485279T1 AT E485279 T1 ATE485279 T1 AT E485279T1 AT 06830756 T AT06830756 T AT 06830756T AT 06830756 T AT06830756 T AT 06830756T AT E485279 T1 ATE485279 T1 AT E485279T1
Authority
AT
Austria
Prior art keywords
benzimidazolylmethylamin
benzamides
salts
preparing
improved method
Prior art date
Application number
AT06830756T
Other languages
English (en)
Inventor
Georg Zerban
Arndt Hausherr
Rainer Hamm
Gunter Koch
Kerstin Schlarb
Heinz-Peter Schmitt
Bjoern Weyell
Original Assignee
Boehringer Ingelheim Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Int filed Critical Boehringer Ingelheim Int
Application granted granted Critical
Publication of ATE485279T1 publication Critical patent/ATE485279T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D235/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/06Benzimidazoles; Hydrogenated benzimidazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
    • C07D235/14Radicals substituted by nitrogen atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
AT06830756T 2005-12-21 2006-12-20 Verbessertes verfahren zur herstellung der salze von 4-(benzimidazolylmethylamin)-benzamiden ATE485279T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE102005061624A DE102005061624A1 (de) 2005-12-21 2005-12-21 Verbessertes Verfahren zur Herstellung von Salzen von 4-(Benzimidazolylmethylamino)-Benzamidinen
PCT/EP2006/070034 WO2007071743A1 (en) 2005-12-21 2006-12-20 Improved process for the preparation of the salts of 4-(benzimidazolylmethylamino)-benzamides

Publications (1)

Publication Number Publication Date
ATE485279T1 true ATE485279T1 (de) 2010-11-15

Family

ID=37950582

Family Applications (1)

Application Number Title Priority Date Filing Date
AT06830756T ATE485279T1 (de) 2005-12-21 2006-12-20 Verbessertes verfahren zur herstellung der salze von 4-(benzimidazolylmethylamin)-benzamiden

Country Status (23)

Country Link
US (1) US7880016B2 (de)
EP (1) EP1968949B1 (de)
JP (1) JP5317702B2 (de)
KR (1) KR101411961B1 (de)
CN (1) CN101346355B (de)
AR (1) AR058571A1 (de)
AT (1) ATE485279T1 (de)
AU (1) AU2006326980B2 (de)
BR (1) BRPI0620150A2 (de)
CA (1) CA2632310C (de)
CY (1) CY1111113T1 (de)
DE (2) DE102005061624A1 (de)
DK (1) DK1968949T3 (de)
ES (1) ES2355045T3 (de)
IL (1) IL192242A (de)
NZ (1) NZ569636A (de)
PL (1) PL1968949T3 (de)
PT (1) PT1968949E (de)
RU (1) RU2425827C2 (de)
SI (1) SI1968949T1 (de)
TW (1) TWI411608B (de)
WO (1) WO2007071743A1 (de)
ZA (1) ZA200804198B (de)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030181488A1 (en) * 2002-03-07 2003-09-25 Boehringer Ingelheim Pharma Gmbh & Co. Kg Administration form for the oral application of 3-[(2-{[4-(hexyloxycarbonylamino-imino-methyl)-phenylamino]-methyl}-1-methyl-1H-benzimidazol-5-carbonyl)-pyridin-2-yl-amino]-propionic acid ethyl ester and the salts thereof
DE10339862A1 (de) * 2003-08-29 2005-03-24 Boehringer Ingelheim Pharma Gmbh & Co. Kg 3-[(2-{[4-(Hexyloxycarbonylamino-imino-methyl)- phenylamino]-methyl}-1-methyl-1H-benzimidazol-5-carbonyl)-pyridin-2-yl-amino]-propionsäure-ethylester-Methansulfonat und dessen Verwendung als Arzneimittel
DE102005061623A1 (de) * 2005-12-21 2007-06-28 Boehringer Ingelheim Pharma Gmbh & Co. Kg Verbessertes Verfahren zur Herstellung von 4-(Benzimidazolylmethylamino)-Benzamidinen und deren Salzen
DE102006054005A1 (de) * 2006-11-16 2008-05-21 Boehringer Ingelheim Pharma Gmbh & Co. Kg Neue Polymorphe von 3-[(2-{[4-(Hexyloxycarbonylamino-imino-methyl)-phenylamino]-methyl}-1-methyl-1H-benzimidazol-5-carbonyl)-pyridin-2-yl-amino]-propionsäure-ethylester
US7767589B2 (en) * 2007-02-07 2010-08-03 Raytheon Company Passivation layer for a circuit device and method of manufacture
US8173906B2 (en) * 2007-02-07 2012-05-08 Raytheon Company Environmental protection coating system and method
EP2288335A1 (de) * 2008-03-28 2011-03-02 Boehringer Ingelheim International GmbH Verfahren zur herstellung von oral verabreichten formulierungen von dabigatran
JP5642670B2 (ja) * 2008-06-16 2014-12-17 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング ダビガトランの合成の中間体の製造方法
BRPI0914788B1 (pt) 2008-06-16 2020-04-07 Boehringer Ingelheim Int processo para produção de um produto intermediário de etexilato de dabigatran
TWI436994B (zh) 2008-07-14 2014-05-11 Boehringer Ingelheim Int 製備含有達比加群(dabigatran)之藥物組合物的新穎方法
AU2009315729A1 (en) 2008-11-11 2010-05-20 Boehringer Ingelheim International Gmbh Method for treating or preventing thrombosis using dabigatran etexilate or a salt thereof with improved safety profile over conventional warfarin therapy
US8399678B2 (en) 2009-11-18 2013-03-19 Boehringer Ingelheim International Gmbh Process for the manufacture of dabigatran etexilate
US20130149346A1 (en) * 2010-03-08 2013-06-13 ratiopharm GmbH Graf-Arco-Strasse 3 Dabigatran etexilate-containing pharmaceutical composition
US9006448B2 (en) * 2010-12-06 2015-04-14 Msn Laboratories Private Limited Process for the preparation of benzimidazole derivatives and its salts
EP2522662A1 (de) 2011-05-11 2012-11-14 Medichem, S.A. Dabigatranetexilat und zugehörige Substanzen, Verfahren und Zusammensetzungen sowie Verwendung der Substanzen als Referenzstandards und Marker
US9273030B2 (en) 2012-04-02 2016-03-01 Msn Laboratories Private Limited Process for the preparation of benzimidazole derivatives and salts thereof
CA2881947A1 (en) 2012-08-31 2014-03-06 Ranbaxy Laboratories Limited Process for the preparation of crystalline form i of methanesulfonate salt of dabigatran etexilate
US9399616B2 (en) 2012-10-22 2016-07-26 Boehringer Ingelheim International Gmbh Process for the manufacture of 4-aminobenzoamidine dihydrochloride
US10077251B2 (en) 2012-10-29 2018-09-18 Biophore India Pharmaceuticals Pvt. Ltd. Process for the synthesis of Dabigatran Etexilate and its intermediates
US9533971B2 (en) 2012-10-29 2017-01-03 Biophore India Pharmaceuticals Pvt. Ltd Process for the synthesis of dabigatran and its intermediates
CN103275065A (zh) * 2013-05-30 2013-09-04 上海同昌生物医药科技有限公司 一种新的生产达比加群酯的方法
EP2835370A1 (de) 2013-08-08 2015-02-11 Medichem, S.A. Neue Kristalle von Dabigatranetexilatmesilat
EP3165521B1 (de) 2014-07-03 2019-01-16 Shanghai Institute Of Pharmaceutical Industry Verfahren zur herstellung eines dabigatran-etexilat-zwischenprodukts und zwischenverbindung
CN105461686A (zh) * 2014-08-25 2016-04-06 江苏豪森药业股份有限公司 制备高纯度甲磺酸达比加群酯晶型的方法
CN104987323B (zh) * 2015-07-10 2017-08-22 浙江美诺华药物化学有限公司 一种达比加群酯的制备方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6087380A (en) 1949-11-24 2000-07-11 Boehringer Ingelheim Pharma Kg Disubstituted bicyclic heterocycles, the preparations and the use thereof as pharmaceutical compositions
PE121699A1 (es) 1997-02-18 1999-12-08 Boehringer Ingelheim Pharma Heterociclos biciclicos disustituidos como inhibidores de la trombina
TWI248435B (en) 1998-07-04 2006-02-01 Boehringer Ingelheim Pharma Benzimidazoles, the preparation thereof and their use as pharmaceutical compositions
US6248770B1 (en) 1998-07-09 2001-06-19 Boehringer Ingelheim Pharma Kg Benzimidazoles having antithrombotic activity
DE19962329A1 (de) 1999-12-23 2001-06-28 Boehringer Ingelheim Pharma Benzimidazole, deren Herstellung und deren Verwendung als Arzneimittel
US6451832B2 (en) 1999-12-23 2002-09-17 Boehringer Ingelheim Pharma Kg Benzimidazoles with antithrombotic activity
ATE540943T1 (de) * 2002-03-07 2012-01-15 Boehringer Ingelheim Pharma 3-ä(2-ää4-(hexyloxycarbonylamino-imino-methyl)- phenylaminoümethylü-1-methyl-1h-benzimidazol-5- carbonyl)-pyridin-2-yl-aminoü-propionsäure- ethylester methansulfonat
NL1026498C2 (nl) * 2004-06-24 2005-12-28 Free Lift B V Hellinglifteenheid met blokkeerinrichting en blokkeerinrichting bestemd voor hellinglifteenheid.
EP1609784A1 (de) * 2004-06-25 2005-12-28 Boehringer Ingelheim Pharma GmbH & Co.KG Verfahren zur Herstellung von 4-(Benzimidazolylmethylamino)-Benzamidinen
DE102005061623A1 (de) * 2005-12-21 2007-06-28 Boehringer Ingelheim Pharma Gmbh & Co. Kg Verbessertes Verfahren zur Herstellung von 4-(Benzimidazolylmethylamino)-Benzamidinen und deren Salzen

Also Published As

Publication number Publication date
CA2632310A1 (en) 2007-06-28
ES2355045T3 (es) 2011-03-22
DE602006017743D1 (de) 2010-12-02
ZA200804198B (en) 2009-04-29
EP1968949A1 (de) 2008-09-17
RU2425827C2 (ru) 2011-08-10
TWI411608B (zh) 2013-10-11
BRPI0620150A2 (pt) 2011-11-01
DK1968949T3 (da) 2011-01-24
KR101411961B1 (ko) 2014-06-27
US20070185173A1 (en) 2007-08-09
KR20080081179A (ko) 2008-09-08
JP2009520766A (ja) 2009-05-28
US7880016B2 (en) 2011-02-01
SI1968949T1 (sl) 2011-02-28
IL192242A0 (en) 2008-12-29
CN101346355A (zh) 2009-01-14
IL192242A (en) 2012-02-29
JP5317702B2 (ja) 2013-10-16
WO2007071743A1 (en) 2007-06-28
AR058571A1 (es) 2008-02-13
PL1968949T3 (pl) 2011-04-29
CA2632310C (en) 2014-02-11
RU2008129637A (ru) 2010-01-27
CN101346355B (zh) 2012-09-05
PT1968949E (pt) 2010-12-22
CY1111113T1 (el) 2015-06-11
AU2006326980B2 (en) 2012-07-05
DE102005061624A1 (de) 2007-06-28
TW200740791A (en) 2007-11-01
AU2006326980A1 (en) 2007-06-28
NZ569636A (en) 2010-04-30
EP1968949B1 (de) 2010-10-20

Similar Documents

Publication Publication Date Title
ATE485279T1 (de) Verbessertes verfahren zur herstellung der salze von 4-(benzimidazolylmethylamin)-benzamiden
DE502006001614D1 (de) Verfahren zur herstellung von 1-alkyl-3-phenyluracilen
ATE516816T1 (de) Verfahren zur herstellung von impfstoffen
DE502005010038D1 (de) Verfahren zur herstellung von 3-pentennitril
DE602005009866D1 (de) Verfahren zur herstellung von n-phenylpyrazol-1-carboxamiden
DE602005018601D1 (de) Verfahren zur herstellung von 2-aminothiazol-5-aro
DE502005002059D1 (de) Verfahren zur herstellung von polyetheralkoholen
DE602005019848D1 (de) Verfahren zur herstellung von tad- getrocknetem ti
ATE554658T1 (de) Verfahren zur herstellung von blatttee
DE602006010302D1 (de) Verfahren zur Herstellung von 5-methyl-2-furfural
ATE533747T1 (de) Verfahren zur herstellung von tetrahydrochinolinderivaten
DE602007009096D1 (de) Verfahren zur herstellung von benzopyran-2-olderivaten
DE602005023438D1 (de) Verfahren zur herstellung von polyestern
DE602006009562D1 (de) Verfahren zur herstellung von ferrisuccinylcasein
ATE546436T1 (de) Verfahren zur herstellung von 2-amino-5- cyanobenzoesäurederivaten
DE602006008306D1 (de) Verfahren zur herstellung von l-threonin
DE602005021110D1 (de) Verfahren zur herstellung von n-piperidino-1,5-diphenylpyrazol-3-carboxamid-derivaten
DE502006004187D1 (de) Verfahren zur herstellung von diorganopolysiloxanen
DE602005014035D1 (de) Verfahren zur Herstellung von Aminen
ATE542533T1 (de) Verfahren zur herstellung von isothiazol- derivaten
DE602006018182D1 (de) Verfahren zur herstellung von aralkyloxypyrrolidinderivaten
DE502006002029D1 (de) Verfahren zur herstellung von polyetheraminen
DE602006017671D1 (de) Verfahren zur herstellung von tricarbonsäuretris(alkylsubstituiertes cyclohexylamid)
DE602006015700D1 (de) Neues verfahren zur herstellung von 5-amino-3h-thiazoloä4,5-düpyrimidin-2-on
ATE521596T1 (de) Verfahren zur herstellung von pyrimidinverbindungen

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1968949

Country of ref document: EP